Welcome to 2nd Annual Metabolic Diseases World Summit

Venue: Long Beach

Location: Long Beach, United States

Event Date/Time: Apr 05, 2006
Report as Spam

Description

Confirmed Speakers For 2nd Annual Metabolic Diseases World Summit

Richard Ho, PhD
Head, Medical Informatics, Johnson & Johnson Pharmaceutical R&D


Peer Jacobson, PhD
Project Leader, Metabolic Disease Research, Abbott Laboratories


Ming Wang, PhD
Department of Metabolic Disorders, Amgen Inc.


David Erbe, PhD
Cardiovascular and Metabolic Diseases, Wyeth Research


Joseph S. Grimsby, Ph.D.
Sr. Research Leader, Metabolic Diseases, Hoffmann-La Roche


Linda Egger, PhD
Assoc Director, Scientific Liaison, External Scientific Affairs, Merck & Co., Inc.


Dr. Doug Greene
Vice President, Product Development, Sanofi Aventis


Te Yuan Kiu, MD
Pfizer, Inc.


Dan Einhorn
Head, Scripps Whittier Diabetes Institute


John Gerich, MD
Clinical Research Center, University of Rochester School of Medicine


Aaron Vinik, MD, PhD
Director of Research, Strelitz Diabetes Institutes, University of Eastern Virginia


Paresh Dandona, MD
Professor of Medicine, University of Buffalo


David Bell, MD
Endocrinologist, University of Alabama at Birmingham School of Medicine


Grant Barish, MD
Howard Hughes Medical Institute and Gene Expression Laboratory, The Salk Institute for Biological Studies


Bernice Welles, MD, MBA
Vice President, Development, DiObex


Tian-Li Yue, PhD
Manager, Investigative & Cardiac Biology, GlaxoSmithKline


Scott Braunstein
JP Morgan


Lois Jovanovic
Sansum Diabetes Research Institute


Wick Johnson, Ph.D.
Director, Licensing & Development, Pfizer Inc


John P. Mayer, PhD
Eli Lilly & Co.


Jean Claude Desmangles
Creighton University


Rolf Thierringer
Department of Cardiovascular Diseases, Merck Research Laboratories


Robert Mashal
President & CEO, Alinea Pharmaceuticals


Joel G Ray, MD MSc FRCPC
Assist Prof & Clinician Scientist, Dept of Med, Div of Endocrinology and Metabolism, University of Toronto


John Holcombe, MD
Medical Fellow, US Diabetes Care, Eli Lilly & Co.


CONFERENCE CHAIRPERSON
Marc Rendell, MD
Creighton University


Lori Gowen Morton
Staff Scientist, Regeneron Pharmaceuticals


Ronald E. Law, PhD, JD
Director, Medical and Scientific Product Evaluation, Takeda Pharmaceuticals North America


John Rodzvilla, MD
Auxilium Pharmaceuticals


Sanjay Bhanot, MD, PhD
Vice President, Metabolic Diseases Research & Development, Isis Pharmaceuticals


Harold Wright
Director, Biology, CytRx Corp


Daniel J. Wilson, MD
Director, Regional Medical Research Specialist Cardiovascular - Midwest, Pfizer Inc.

Venue